Is it feasible to design a nanosystem loaded with anti-TB therapeutic to actively target the alveolar macrophages via ORAL DELIVERY?

Recent advances on delivery of anti-TB therapeutics focus on the pulmonary route of administration. Most studies actively target the alveolar macrophages via surface modification of nanoparticles...

14 March 2018 702 3 View